Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Vol. 17, 04 December 2023
* Author to whom correspondence should be addressed.
Colorectal cancer (CRC) is a formidable global health challenge, with increasing incidence rates and significant mortality. Flavonoids, known for their antioxidant properties, a class of polyphenolic compounds found in various dietary sources, exert multifaceted effects on gut microbiota composition, short-chain fatty acids (SCFAs) production, inflammation mitigation, and gut barrier enhancement. Moreover, they demonstrate promise in countering DNA damage induced by microbial toxins and modulating metabolic processes. Animal studies and clinical trials revealed changes in gut microbiota composition in CRC. However, the translational application of flavonoids to treat CRC through modifying gut microbiota requires further research. This review paper delves into the intricate relationship between flavonoids, and gut microbiota, with a particular focus on their potential in CRC prevention. This paper discusses the complex mechanisms through which flavonoids influence CRC development and highlights their potential in shaping dietary strategies for cancer prevention. In the midst of the rising CRC burden, flavonoids offer a hopeful link between dietary choices and improved health outcomes, paving the way for a healthier, cancer-free future.
Flavonoids, Gut Microbiota, Colorectal Cancer
1. Dekker E., Tanis P. J., Vleugels J. L., Kasi P. M., and Wallace, M. B. 2019 The Lancet 394 1467-80
2. Boakye D., Rillmann B., Walter V., Jansen L., Hoffmeister M., and Brenner H. 2018 Cancer Treat. Rev. 64 30–9
3. Slika, H., Mansour, H., Wehbe, N., Nasser, S. A., Iratni, R., Nasrallah, G., Shaito, A., Ghaddar, T., Kobeissy, F., and Eid, A. H. 2022 Biomed. Pharmacother 146 112-442
4. Rauter, Amélia P., Ennis, Marcus, Hellwich, Karl-Heinz, Herold, Bernardo J., Horton, Derek, Moss, Gerard P. and Schomburg, Ida. Pure Appl. Chem. 2018 90 1429-86
5. Ravishankar, D., Rajora, A. K., Greco, F., & Osborn, Helen. M. I. 2013 Int. J. Biochem. Cell Biol. 45 2821–31
6. Zhao, L.-Y., Mei, J.-X., Yu, G., Lei, L., Zhang, W.-H., Liu, K., Chen, X.-L., Kołat, D., Yang, K., and Hu, J.-K. 2023 Signal Transduct Target Ther 8
7. Wong, S. H., and Yu, J. 2019 Nat. Rev. Gastroenterol. Hepatol. 16 690–704
8. Li, Y., Kundu, P., Seow, S. W., de Matos, C. T., Aronsson, L., Chin, K. C., Kärre, K., Pettersson, S., and Greicius, G. 2012 Carcinogenesis 33 1231–8
9. Wang, M., Yu, F., Zhang, Y., Chang, W., and Zhou, M. 2022 Int. J. Biol. Sci. 18 1451–75
10. Matthew R. Wilson et al. 2019 Science 363 7785
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).